63 related articles for article (PubMed ID: 22571348)
1. Hepatic sinusoidal obstruction syndrome (SOS) reduces the effect of oxaliplatin in colorectal liver metastases.
Vreuls CP; Van Den Broek MA; Winstanley A; Koek GH; Wisse E; Dejong CH; Olde Damink SW; Bosman FT; Driessen A
Histopathology; 2012 Aug; 61(2):314-8. PubMed ID: 22571348
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model.
Robinson SM; Mann J; Vasilaki A; Mathers J; Burt AD; Oakley F; White SA; Mann DA
J Hepatol; 2013 Aug; 59(2):318-26. PubMed ID: 23624001
[TBL] [Abstract][Full Text] [Related]
3. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes.
Yang XQ; Ye J; Li X; Li Q; Song YH
World J Gastroenterol; 2019 Jul; 25(28):3753-3763. PubMed ID: 31391770
[TBL] [Abstract][Full Text] [Related]
4. Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy.
Seo AN; Kim H
Clin Mol Hepatol; 2014 Mar; 20(1):81-4. PubMed ID: 24757663
[No Abstract] [Full Text] [Related]
5. Oxaliplatin-induced hepatic sinusoidal obstruction syndrome.
Zhu C; Ren X; Liu D; Zhang C
Toxicology; 2021 Aug; 460():152882. PubMed ID: 34352347
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.
Corbacioglu S; Jabbour EJ; Mohty M
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1271-1280. PubMed ID: 30797942
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Volume Fraction Calculated Using Contrast-Enhanced Computed Tomography as a Biomarker of Oxaliplatin-Induced Sinusoidal Obstruction Syndrome: A Preliminary Histopathological Analysis.
Kai K; Hamada T; Sato Y; Hiyoshi M; Imamura N; Yano K; Ikeda T; Ichihara A; Ogata S; Choijookhuu N; Hishikawa Y; Hosokawa A; Nanashima A
J Oncol; 2023; 2023():1440257. PubMed ID: 36824665
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin-induced sinusoidal obstruction syndrome mimicking metastatic colon cancer in the liver.
Choi JH; Won YW; Kim HS; Oh YH; Lim S; Kim HJ
Oncol Lett; 2016 Apr; 11(4):2861-2864. PubMed ID: 27073565
[TBL] [Abstract][Full Text] [Related]
9. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease).
Fan CQ; Crawford JM
J Clin Exp Hepatol; 2014 Dec; 4(4):332-46. PubMed ID: 25755580
[TBL] [Abstract][Full Text] [Related]
10. Case report: Oxaliplatin-induced idiopathic non-cirrhotic portal hypertension: a case report and literature review.
Ye J; Xie Y; Xu Y; Chen N; Tu Y
Front Med (Lausanne); 2023; 10():1285064. PubMed ID: 38089870
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Vascular Endothelial Growth Factor Protects against the Development of Oxaliplatin-Induced Sinusoidal Obstruction Syndrome in Wild-Type but Not in CD39-Null Mice.
Knitter S; Duwe G; Beierle AS; Pesthy S; Ritschl PV; Hillebrandt KH; Arnold A; Malinka T; Modest DP; Bahra M; Pratschke J; Sauer IM; Schmelzle M; Andreou A
Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497474
[TBL] [Abstract][Full Text] [Related]
12. Model establishment and microarray analysis of mice with oxaliplatin‑induced hepatic sinusoidal obstruction syndrome.
Zhu C; Cheng X; Gao P; Gao Q; Wang X; Liu D; Ren X; Zhang C
Mol Med Rep; 2022 Nov; 26(5):. PubMed ID: 36177905
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric MRI with MR elastography findings in patients with sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy.
Poker A; Karcaaltıncaba M; Ozmen MN; Karaosmanoğlu AD; Erdemir AG; Ocal O; Akata D; Idilman IS
Insights Imaging; 2022 Sep; 13(1):147. PubMed ID: 36064860
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of ultrasonography and elastography in diagnosing oxaliplatin-induced sinusoidal obstruction syndrome.
Saito R; Kawamoto Y; Nishida M; Iwai T; Kikuchi Y; Yokota I; Takagi R; Yamamura T; Ito K; Harada K; Yuki S; Komatsu Y; Sakamoto N
Int J Clin Oncol; 2022 Nov; 27(11):1780-1790. PubMed ID: 36042137
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin-related Portal Hypertension Complicated with Esophageal Varices and Refractory Massive Ascites.
Yazaki T; Kawashima K; Ishimura N; Kataoka M; Fukunaga M; Hyakudomi R; Tajima Y; Moriyama I; Araki A; Kadota K; Shibagaki K; Tobita H; Ishihara S
Intern Med; 2022 Nov; 61(21):3225-3231. PubMed ID: 35370236
[TBL] [Abstract][Full Text] [Related]
16. Fat causes necrosis and inflammation in parenchymal cells in human steatotic liver.
Wisse E; Braet F; Shami GJ; Zapotoczny B; Vreuls C; Verhaegh P; Frederik P; Peters PJ; Olde Damink S; Koek G
Histochem Cell Biol; 2022 Jan; 157(1):27-38. PubMed ID: 34524512
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value/performance of radiological liver imaging during chemoterapy for gastrointestinal malignancy: a critical review.
Reginelli A; Vacca G; Zanaletti N; Troiani T; Natella R; Maggialetti N; Palumbo P; Giovagnoni A; Ciardiello F; Cappabianca S
Acta Biomed; 2019 Apr; 90(5-S):51-61. PubMed ID: 31085973
[TBL] [Abstract][Full Text] [Related]
18. Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer.
Jarzabek MA; Proctor WR; Vogt J; Desai R; Dicker P; Cain G; Raja R; Brodbeck J; Stevens D; van der Stok EP; Martens JWM; Verhoef C; Hegde PS; Byrne AT; Tarrant JM
PLoS One; 2018; 13(6):e0198099. PubMed ID: 29879147
[TBL] [Abstract][Full Text] [Related]
19. The hepatoprotective role of reduced glutathione and its underlying mechanism in oxaliplatin-induced acute liver injury.
Lin Y; Li Y; Hu X; Liu Z; Chen J; Lu Y; Liu J; Liao S; Zhang Y; Liang R; Lin Y; Li Q; Liang C; Yuan C; Liao X
Oncol Lett; 2018 Feb; 15(2):2266-2272. PubMed ID: 29403564
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis.
Stevenson HL; Prats MM; Sasatomi E
BMC Cancer; 2017 Jan; 17(1):35. PubMed ID: 28061766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
